Outset Medical, Inc. (OM)
Chart Events
Performance Outlook
| Previous Close | 10.96 |
| Open | 11.06 |
| Bid | 10.99 x 800 |
| Ask | 11.01 x 900 |
| Day's Range | 10.91 - 11.22 |
| 52 Week Range | 10.67 - 30.55 |
| Volume | |
| Avg. Volume | 529,860 |
| Market Cap | 550.68M |
| Beta (5Y Monthly) | 1.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.46 |
| Earnings Date | Nov 06, 2023 - Nov 10, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.60 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for OM
Related Research
- Outset Medical, Inc.PGNY: Lowering target price to $39.00PROGYNY INC has an Investment Rating of BUY; a target price of $39.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.RatingFair ValueEconomic Moat7 days agoArgus Research
Business WireOutset Medical to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
SAN JOSE, Calif., August 29, 2023--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, September 12, 2023 at 11:55am PT / 2:55pm ET.
Motley FoolInvestors Look at Apple, Amazon, and More
Motley Fool contributor Rick Munarriz weighs in on the state of Disney's Marvel and whether it can recapture the box office magic any time soon. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.
ZacksOutset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of 5.48% and 2.46%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
